01412nas a2200445   4500000000100000008004100001260001700042653001500059653001000074653002600084653002700110653002900137653001100166653001000177653002100187653001100208653003500219653001100254653001100265653001300276653001200289653000900301653002500310653001700335653001100352100001100363700001700374700001800391700001500409700001200424700001900436700001000455700001600465245007500481300001200556490000700568050003200575520034500607022001400952       1985                            d  c1985 Oct-Dec10aAdolescent10aAdult10aAntibodies, Bacterial10aAntibodies, Monoclonal10aAntigen-Antibody Complex10aBiopsy10aChild10aChild, Preschool10aFemale10aFluorescent Antibody Technique10aHumans10aInfant10aLepromin10aleprosy10aMale10aMycobacterium leprae10aNasal Mucosa10aSepsis1 aRamu G1 aMalaviya G N1 aBharadwaj V P1 aSengupta U1 aSinha S1 aRamanathan V D1 aPal C1 aDesikan K V00aStudies on healthy contacts of leprosy patients--a preliminary report.  a796-8030 v57  aInfolep Library - available3 a<p>91 healthy contacts of leprosy patients were studied for subclinical infection and possibly the pre-clinical stage of the disease using a battery of tests. It was observed that the test based on competitive inhibition of monoclonal antibody binding to the MY2 a determinant of M. leprae identifies a preclinical stage of the disease.</p>  a0254-9395